EV/EBITDA Multiple: Scienture (SCNX)
The current price action for Scienture Holdings Inc (SCNX) displayed on the GURU.Markets platform reflects an EV/EBITDA multiple of 0.00. The business relies on the development of safe injectables, which ensures high service pricing with low price elasticity of demand. Despite pressure from tech behemoths competing for hospital contracts, Scienture Holdings Inc maintains a flawless image and a strict commitment to quality standards.
Analytical breakdowns for Scienture Holdings Inc. (SCNX)
- current price and projected stock value:
- company stock exchange capitalization indicators:
- issuer book value statistics:
- company liabilities and liquidity data:
Total Debt to Equity Ratio Scienture Holdings Inc|SCNX - Long-Term Loans to Capital Ratio|Short-Term Debt to Equity Ratio Scienture Holdings|SCNX - Company Aggregate Debts|Debt to Book Capitalization Ratio Scienture Holdings Inc|SCNX - Company Long-Term Loans and Borrowings|Company Short-Term Debts Scienture|Quick Liquidity Indicator scienture.com
- financial results and valuation multiples details:
SCNX - Final Profit|Projected Future Earnings Scienture Holdings Inc|SCNX - Company Value to Net Income|Future Price to Earnings Scienture Corp|SCNX - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Scienture Holdings|SCNX - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) Scienture|SCNX - Earnings per share for the last 12 months|Quarterly EPS earnings growth scienture.com|SCNX - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Scienture Holdings Inc
- revenue and sales details:
Fundamental company analysis:SCNX (Scienture Holdings Inc)
This indicator compares the total enterprise value, including net debt, with operational efficiency before depreciation and amortization to determine the asset's fair value and the extent of its debt load. For Scienture Holdings Inc (SCNX), which utilizes the 505(b)(2) pathway for accelerated drug launches, the EV/EBITDA ratio—accounting for operating profit and amortization—serves as a benchmark for the balance between innovation capital expenditures and actual returns, signaling whether the shares are overvalued or undervalued.
Key competitors
EV/EBITDA Multiple VEEV (Veeva Systems)|Doximity (DOCS) - Company Value to EBITDA|HQY - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio Waystar Inc. WAY|CRVL (CorVel Healthcare) - Enterprise Value to EBITDA Ratio|PRVA (Privia Health Corp) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Huron|EV/EBITDA Multiple certara.com|EV/EBITDA Multiple OMCL|GoodRx Corp - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple SDGR (Schrodinger Corp)|EV/EBITDA Multiple Phreesia, Inc. PHR|Omada Health, Inc. - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation EVH (Evolent Health, Inc.)|HealthStream (HSTM) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Definitive Healthcare Corp. - Business Value to Operating Income Before Depreciation|Enterprise Value to EBITDA Ratio CCSI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization AGL|Enterprise Value to EBITDA Ratio ABSI (Absci Corp.)|SY - Company Value to EBITDA|EV/EBITDA Multiple NRC (NRC Health Inc.)|Enterprise Value to EBITDA Multiple Spok Holdings Inc|OPRX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TruBridge, Inc. (TBRG) - Enterprise Value to EBITDA Ratio|SLP (Simulations Plus Inc.) - Enterprise Value to EBITDA Ratio|Enterprise Value to EBITDA Ratio SOPHiA GENETICS S.A.|Enterprise Value to EBITDA Ratio HCAT|Enterprise Value to EBITDA Ratio CareCloud, Inc. (CCLD)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Research Solutions Inc. (RSSS)|DLHC (DLH Corp) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple ONMD (OneMedNet Corp)|Enterprise Value to EBITDA Multiple healthcaretriangle.com|iSpecimen - EV/EBITDA Multiple|BFRG (bullfrogai.com) - Enterprise Value to Operating Income Before Depreciation|WORX (SCWorx Corporation) - Enterprise Value to EBITDA Ratio|Company Value to Operating Income Before Depreciation Ratio MSPR (MSP Recovery Corp)|ICCT (icoreconnect.com) - EV/EBITDA Multiple|Company Value to EBITDA TRxADE HEALTH, Inc. MEDS|Enterprise Value to EBITDA Ratio ORGS (Orgenesis)|RCM (R1 RCM, Inc.) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Sharecare Inc SHCR|EV/EBITDA Multiple Streamline Health Solutions STRM|SYRA: Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio apollomed.net AMEH|Model N Corporation (MODN) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|NXGN: Enterprise Value to Operating Income Before Depreciation Ratio
